Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Wall Street Analysts Think Immunovant (IMVT) Could Surge 68.63%: Read This Before Placing a Bet
Wall Street Analysts Think Immunovant (IMVT) Could Surge 68.63%: Read This Before Placing a Bet
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
Should You Hold Immunovant (IMVT)?
Should You Hold Immunovant (IMVT)?
Here's Why You Should Add Immunovant (IMVT) to Your Portfolio
Here's Why You Should Add Immunovant (IMVT) to Your Portfolio
Here's Why You Should Add Immunovant (IMVT) to Your Portfolio
What Makes Immunovant (IMVT) a New Buy Stock
What Makes Immunovant (IMVT) a New Buy Stock
What Makes Immunovant (IMVT) a New Buy Stock
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?
Immunovant Awarded U.S. Patent for IMVT-1402
Here's Why Immunovant, Inc. (IMVT) is Poised for a Turnaround After Losing -8.02% in 4 Weeks
Here's Why Immunovant, Inc. (IMVT) is Poised for a Turnaround After Losing -8.02% in 4 Weeks
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.